• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Store » July 1999 – The CenterWatch Monthly : PDF
July 1999 – The CenterWatch Monthly : PDF

July 1999 – The CenterWatch Monthly : PDF

$79.00

Product Details

Pediatric Trials On the Verge

As FDAMA Section 111 approaches, investigative sites and CROs are rapidly building capabilities to exploit the expected growth in pediatric clinical trials.

At this time, major medical centers appear to be the best positioned investigative site segment to grab the pediatric clinical trials market.

At Last! Development Cycle Times Shorten

Reversing a 12-year trend, clinical phase (I-III) durations from 1996 to 1998 are 18% faster. In that same period, regulatory approval times have declined by 30%.

Sponsors will need to continuously improve collaborative effectiveness with CROs and investigative sites to maintain and exceed clinical cycle time acceleration

Also in this issue:

  • CentreStage Europe: European CRO Market Outpaces US Market
  • Eye On Urinary Incontinence

 

  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing